Abstract:Pneumonia is a condition characterized by lung damage resulting from a robust immune response by the host. While the defense and immunity against bacterial lung infections have been extensively studied, little is known about the specific immune factors involved in the progression of bacterial pneumonia. To address this knowledge gap, our study aimed to compare normal lung tissues with pneumonia tissues using various techniques, including HE staining, RNA sequencing, RT‐PCR, and Elisa assay. Our analysis revealed a significant increase in the levels of interleukin‐6 (IL‐6) in pneumonia tissues compared to normal lung tissues. To further investigate the underlying mechanism, we extracted exosomes from both pneumonia and normal lung tissues using ultracentrifugation. The exosomes were then examined using electron microscopy, diameter analysis, and western blot assay. RNA sequencing of the exosomes revealed an upregulation of several microRNAs (miRNAs), with miR‐362 exhibiting the most significant change. This finding was confirmed through RT‐PCR analysis conducted on lung tissues and alveolar lavage fluid. To gain insights into the specific target genes of miR‐362, we employed bioinformatics analysis, which identified VENTX as a potential target gene. This finding was further validated through RT‐PCR, western blot, and luciferase assay. Our experimental evidence demonstrated that miR‐362 regulates VENTX expression, as evidenced by the use of miR‐362 mimics or inhibitors on lung cells. Furthermore, we discovered that exosomes derived from pneumonia tissues upregulate IL‐6 production through the miR‐362/VENTX axis. Importantly, the blocking of IL‐6 generation, which is facilitated by miR‐362 inhibitor and VENTX overexpression lentivirus, can be achieved by treating exosomes. Moreover, we conducted in vivo experiments using pneumonia models. Rats were treated with IL‐6, miR‐362 mimics, or VENTX knock‐down lentivirus. The results demonstrated a worse prognosis for rats treated with these factors, indicating their potential as prognostic markers. Taken together, our study suggests that exosomes facilitate IL‐6 generation by transferring miR‐362, thereby suppressing VENTX transcription. Consequently, the IL‐6/miR‐362/VENTX axis emerges as a promising therapeutic target for pneumonia.

Let7f‑5p Attenuates Inflammatory Injury in in Vitro Pneumonia Models by Targeting MAPK6.

let7f‐5p attenuates inflammatory injury in i n vitro pneumonia models by targeting MAPK6

MicroRNA‑129 Plays a Protective Role in Sepsis‑induced Acute Lung Injury Through the Suppression of Pulmonary Inflammation Via the Modulation of the TAK1/NF‑κB Pathway.

Methylation of miR‐19b‐3p promoter exacerbates inflammatory responses in sepsis‐induced ALI via targeting KLF7

MiR-103a-3p antagonism attenuates pneumonia via inactivating the PI3K/AKT/NF-κB signaling pathway by targeting PTEN

MicroRNA Let-7C Improves LPS-Induced Outcomes of Endometritis by Suppressing NF-κB Signaling

Inhibition of Myosin Light-Chain Kinase Enhances the Clearance of Lipopolysaccharide-Induced Lung Inflammation Possibly by Accelerating Neutrophil Apoptosis.

Anti-inflammatory Role of Microrna Let-7C in LPS Treated Alveolar Macrophages by Targeting STAT3.

Long Non-Coding RNA (lncRNA) CRNDE Regulated Lipopolysaccharides (LPS)-Induced MRC-5 Inflammation Injury Through Targeting MiR-141

Inhibition of miR-29b-1-5p Attenuates Inflammatory Response and Pulmonary Fibrosis in LPS-Induced Acute Lung Injury by Regulating RTN4 Expression

RETRACTED: Inhibition of miR-29b-1-5p Attenuates Inflammatory Response and Pulmonary Fibrosis in LPS-Induced Acute Lung Injury by Regulating RTN4 Expression (Retracted Article)

MicroRNA-7 Deficiency Ameliorates the Pathologies of Acute Lung Injury through Elevating KLF4

Identification of Mirna Biomarkers of Pneumonia Using RNA-sequencing and Bioinformatics Analysis.

MicroRNA-194 Regulates Lipopolysaccharide-Induced Cell Viability by Inactivation of Nuclear Factor-κ B Pathway.

MiR-297 Alleviates LPS-induced A549 Cell and Mice Lung Injury Via Targeting Cyclin Dependent Kinase 8

Deregulated Expression of miR-483-3p Serves as a Diagnostic Biomarker in Severe Pneumonia Children with Respiratory Failure and Its Predictive Value for the Clinical Outcome of Patients

Downregulation of IGFBP7 Alleviates LPS-induced Inflammation and Apoptosis in WI-38 Cells via Enhancing Mitophagy

MicroRNA (Mir)-429 Promotes Inflammatory Injury by Targeting Kruppel-Like Factor 4 (KLF4) in Neonatal Pneumonia.

MK2 Mediates Macrophage Activation and Acute Lung Injury by Regulating Let-7E Mirna

Modulation of the Inflammatory Response Tostreptococcus Pneumoniaein a Model of Acute Lung Tissue Infection

Exosomes derived miR‐362 exacerbates pneumonia by increasing Interleukin‐6 via targeting VENTX